RXi Pharmaceuticals CEO Gerrit Dispersyn's 2022 pay falls 35% to $490K
RXi Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: June 9, 2023
RXi Pharmaceuticals reported fiscal year 2022 executive compensation information on June 9, 2023.
In 2022, three executives at RXi Pharmaceuticals received on average a compensation package of $226K, a 24% decrease compared to previous year.
Average pay of disclosed executives at RXi Pharmaceuticals
Gerrit Dispersyn, Chief Executive Officer, received $490K in total, which decreased by 35% compared to 2021.
Robert J. Bitterman, Chief Executive Officer, received a compensation package of $109K, which increased by 40% compared to previous year. 71% of the compensation package, or $78K, was in salary.
Geert Cauwenbergh, Former interim Principal Executive and Financial Officer, earned $77K in 2022, a 33% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on June 9, 2023.